Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3Active not recruiting 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 7Papillomavirus Infections 6Neoplasms 5Breast Neoplasms 4Uterine Cervical Dysplasia 3Melanoma 3Lung Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Vulvar Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Anus Neoplasms 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Sarcoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Persistent Infection 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Nasopharyngeal Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 7Papillomavirus Vaccines 6Vaccines 3Imiquimod 3Gels 3green tea extract polyphenone E 2Trichloroacetic Acid 2Duration of Therapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1berdazimer sodium 1Viusid 1VP-102 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1Omiganan 1Ointments 1Medical Records 1Interleukin-4 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1GS-9191 1Ethanol 1Cyclophosphamide 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Condylomata Acuminata × Vaccines × Clear all
NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 2 Completed
780 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 1 Completed
160 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT00501137 2015-04-10

BCGov-01

University of British Columbia

Phase 3 Completed
830 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡